Public health officials point to recent measles cases in Ontario to underscore the case for an electronic vaccination registry | Unpublished
Hello!
Source Feed: The Globe and Mail
Author: Kristy Kirkup
Publication Date: April 3, 2025 - 17:32

Public health officials point to recent measles cases in Ontario to underscore the case for an electronic vaccination registry

April 3, 2025
The sharp increase in measles cases in Ontario – including another 89 last week – underscores the urgent need for an electronic system to record vaccinations, public health experts say.According to new data released by Public Health Ontario on Thursday, Ontario recorded a total of 661 measles cases (520 confirmed, 121 probable) associated with an outbreak in 13 public health units between Oct. 18 of last year and April 2, 2025.The majority of cases have been among unimmunized individuals in the Southwestern Public Health and Grand Erie Public Health units. In its own measles report released Thursday, Southwestern said it had recorded 18 cases in the past seven days and 306 since last October.


Unpublished Newswire

 
William Nylander and Nick Robertson had two goals apiece as the Toronto Maple Leafs blanked the Columbus Blue Jackets 5-0 on Saturday for their fourth straight victory.
April 5, 2025 - 21:44 | Globalnews Digital | Global News - Ottawa
Parliament Hill's East Block was locked down Saturday after a man barricaded himself in the building, sparking a major police intervention that lasted for hours. Read More
April 5, 2025 - 20:20 | Gord Holder, Postmedia | Ottawa Citizen
Two Canadian researchers were among the winners named at this year’s Breakthrough Prize ceremony on Saturday. The annual event, held in Los Angeles, celebrates the world’s largest science awards with a dose of Hollywood glam.Daniel Drucker, a physician and senior investigator at Toronto’s Lunenfeld-Tanenbaum Research Institute, was one of five researchers jointly awarded a US$3-million Breakthrough Prize in Life Sciences for discoveries leading to the development of a class of drugs that are now widely used in the treatment of Type 2 diabetes and obesity.
April 5, 2025 - 19:48 | Ivan Semeniuk | The Globe and Mail